Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Intensive care for CAR-T: bridge to treatment and response

The importance of intensive medicine in the management of patients treated with CAR T-cells should not be underestimated. Speaking from the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, Michael von Bergwelt, MD, PhD, of LMU Hospital Munich, Munich, Germany, discusses the importance of intensive care in this field, highlighting the capacity, resources and training issues that need to be addressed.